Rewards
All
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
My Bing
Notebook
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
Trending on Bing
Sues OpenAI, Microsoft
5 takeaways from debate
Sentenced to life in prison
Mammoths death mystery
Monolith appears in Colo.
Bid to reach Olympics ends
Belongings sold for $1.5M+
US protects Alaska lands
Recalls working w/ Andrews
Mich. woman to stand trial
Condemns racist abuse
New duet 'Cowboys Cry Too'
1976 cold case victim ID’d
Patriot systems to UKR?
US sends assault ship
Oakland firefighter drowns
Premium adds new features
Ex-Uvalde chief arrested
7 hikers hospitalized
Princess Anne discharged
Wildfire prompts evacuation
Joins 'Dexter' prequel
Medical marijuana program
US service member charged
Wins Hart, Lindsay awards
Gaza aid peer review
Baseus power banks recalled
Iowa abortion law hearing
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
Novo Nordisk invests $4.1B to expand manufacturing
Ozempic craze: Novo Nordisk invests $4.1B in US to expand manufacturing
Novo Nordisk is investing $4.1 billion to expand its U.S. manufacturing capacity to address the growing demand for its highly sought-after weight-loss-related drugs. The Danish pharmaceutical manufacturer will also boost its current production investment this year to $6.
Wegovy-maker Novo Nordisk to spend $4.1 bln to boost US manufacturing
Obesity drug-maker Novo Nordisk will spend $4.1 billion to build a U.S. facility to fill injection pens for its hugely popular weight-loss treatment Wegovy and diabetes drug Ozempic, it said on Monday.
Novo Nordisk to build $4.1 billion North Carolina facility to boost output of Wegovy, Ozempic
The new plant in Clayton, North Carolina, will be responsible for filling and packaging syringes and injection pens for Wegovy, Ozempic and other drugs.
The Financial Times
4d
Novo Nordisk invests $4bn to expand weight loss drug production in US
Roula Khalaf, Editor of the FT, selects her favourite stories in this weekly newsletter.
Novo
Nordisk
is investing $4.1bn ...
pharmaphorum
4d
Novo Nordisk pledges $4.1bn for US injectables plant
Novo
Nordisk
has gone up another gear in its drive
to boost
manufacturing
capacity for its fast-growing GLP-1 agonist ...
ENDPOINTS NEWS
3d
Novo Nordisk budgets $4.1B for new US manufacturing site as it abandons plans for Irish build
Novo Nordisk is further boosting manufacturing in the US for its obesity drugs as it injects $4.1 billion for a second ...
Benzinga.com on MSN
3d
Wegovy, Ozempic Maker Novo Nordisk To Invest $4.1B In US Manufacturing, Doubling Plant Size To Meet Surging Demand For Weight Loss Drugs
Novo
Nordisk
A/S NVO is set to invest $4.1 billion in expanding its
U.S
.
manufacturing
operations to meet the ...
U.S. News & World Report
3d
Wegovy-Maker Novo Nordisk to Spend $4.1 Billion to Boost US Manufacturing
COPENHAGEN/LONDON (Reuters) - Obesity drug-maker
Novo
Nordisk
will spend $4.1 billion to build a
U.S
. facility to fill ...
Yahoo
3d
Wegovy-maker Novo Nordisk to spend $4.1 billion to boost US manufacturing
COPENHAGEN/LONDON (Reuters) - Obesity drug-maker
Novo
Nordisk
will spend $4.1 billion to build a
U.S
. facility to fill injection pens for its hugely popular weight-loss treatment Wegovy and ...
2d
on MSN
Novo Nordisk introduces Wegovy amid soaring obesity rates
Novo Nordisk.. Danish pharmaceutical company which is known for several medicines involving weight loss is all set to enter ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Related topics
United States
Ozempic
Wegovy